Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ONCOARENDI THERAP ZY-,01
No Price
Closing Price XWAR 30.04.2026:
5,64 PLN
30.04.2026 15:00
Current Prices from ONCOARENDI THERAP ZY-,01
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
WSE
MOC.WA
PLN
30.04.2026 15:00
5,64 PLN
-
Share Float & Liquidity
Free Float79,21 %
Shares Float16,32 M
Shares Outstanding20,6 M
Company Profile for ONCOARENDI THERAP ZY-,01 Share
Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. It is involved in the development of OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has completed phase I clinical trial for the treatment of idiopathic pulmonary fibrosis and sarcoidosis; YKL-40 program for the treatment of cancer and fibrosis; OATD-02 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.
